Published in Managed Care Law Weekly, April 26th, 2009
The ratings reflect Blue Whale Re’s strong capitalization and its conservative operating strategy. The ratings also consider its critical and central role and favorable profile as part of Pfizer Inc. (Pfizer) (NYSE: PFE), as well as the company’s excellent operating performance. Partially offsetting these positive rating factors are the company’s very large gross and net underwriting exposures to property losses and its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.